Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Antidepressant-Like Effect of Deep Brain Stimulation: Neurobiological and Neurogenic Mechanisms

EF 2009-10

Résumé
Depression is a debilitating psychiatric illness affecting about 10% of the population in any given one-year period. Symptoms include low mood, lack of motivation and suicidal thoughts. It is projected to be a leading cause of disability by 2010. A staggering health care cost is allotted to manage depression. Although, several types of antidepressant drugs are available, these possess many limitations in efficacy. For example, these drugs curb symptoms only after several weeks of continuously taking them. A third of patients do not respond at all to these drugs and many more treated patients experience relapse. Furthermore, our understanding about depression is not complete. It is a complex disorder likely affecting many aspects of the brain, including chemical deficiency and cell death. There is a pressing need to explore alternative treatments. A potential novel treatment approach is called deep brain stimulation (DBS). This technology involves implanting an electrode that delivers electrical current into brain regions adversely affected in depression. The prefrontal cortex and the medial cerebellum, brain structures involved in cognitive, psychomotor and emotion-related functions, have been stimulated using DBS in depressed patients, as well as, in animals showing depression-like behaviours. These attempts to assess DBS for depression have proven to be promising, with patients completely improving symptoms. However, the mechanisms and principles by which DBS conveys its effectiveness remain poorly understood. We shall therefore examine DBS, using animal subjects, on its ability to modify protein interactions commonly affected by antidepressants, and to enhance cell birth in the hippocampus, a structure known to be modified by antidepressant drugs. It is necessary to exhaustively understand these mechanisms in order to gain more insights into the cause of depression, better characterize the effects of this disease in the brain, and optimize treatment efficacy.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Connecticut, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
203469
Name
Bambico Francis R
Region
Connecticut
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Antidepressant-Like Effect of Deep Brain Stimulation: Neurobiological and Neurogenic Mechanisms
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Animal Behaviour; Deep Brain Stimulation; Depression; Hippocampus; Limbic Cerebellum; Neurogenesis; Neurotrophic Factors; Prefrontal Cortex
Abstract
Depression is a debilitating psychiatric illness affecting about 10% of the population in any given one-year period. Symptoms include low mood, lack of motivation and suicidal thoughts. It is projected to be a leading cause of disability by 2010. A staggering health care cost is allotted to manage depression. Although, several types of antidepressant drugs are available, these possess many limitations in efficacy. For example, these drugs curb symptoms only after several weeks of continuously taking them. A third of patients do not respond at all to these drugs and many more treated patients experience relapse. Furthermore, our understanding about depression is not complete. It is a complex disorder likely affecting many aspects of the brain, including chemical deficiency and cell death. There is a pressing need to explore alternative treatments. A potential novel treatment approach is called deep brain stimulation (DBS). This technology involves implanting an electrode that delivers electrical current into brain regions adversely affected in depression. The prefrontal cortex and the medial cerebellum, brain structures involved in cognitive, psychomotor and emotion-related functions, have been stimulated using DBS in depressed patients, as well as, in animals showing depression-like behaviours. These attempts to assess DBS for depression have proven to be promising, with patients completely improving symptoms. However, the mechanisms and principles by which DBS conveys its effectiveness remain poorly understood. We shall therefore examine DBS, using animal subjects, on its ability to modify protein interactions commonly affected by antidepressants, and to enhance cell birth in the hippocampus, a structure known to be modified by antidepressant drugs. It is necessary to exhaustively understand these mechanisms in order to gain more insights into the cause of depression, better characterize the effects of this disease in the brain, and optimize treatment efficacy.
Competitiondate
201002
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bambico, Francis R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~